查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1434964

脫髮症治療市場：按疾病類型、給藥途徑、性別、治療選擇和最終用戶 - 2024-2030 年全球預測

Alopecia Treatment Market by Disease Type (Alopecia Areata, Alopecia Totalis, Alopecia Universalis), Route of Administration (Injectable, Oral, Topical), Gender, Treatment Option, End User - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年脫髮症治療市場規模為32.6億美元，預計2024年將達35.3億美元，2030年將達到56.9億美元，複合年成長率為8.27%。

全球脫髮症治療市場

主要市場統計
基準年[2023] 32.6億美元
預測年份 [2024] 35.3億美元
預測年份 [2030] 56.9億美元
複合年成長率（%） 8.27%
脫髮治療市場-IMG1

FPNV定位矩陣

FPNV定位矩陣對於評估脫髮症治療市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標，以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估，供應商被分為四個成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對脫髮症治療市場供應商的現狀進行深入而深入的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻，以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外，該分析還提供了對該行業競爭特徵的寶貴見解，包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。這種詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略，從而在市場上獲得競爭優勢。

該報告對以下幾個方面提供了寶貴的見解：

1-市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2-市場開拓：我們深入研究利潤豐厚的新興市場，並分析它們在成熟細分市場中的滲透率。

3- 市場多元化：提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。

4-競爭力評估與資訊：對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況、製造能力等進行全面評估。

5- 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告解決了以下關鍵問題：

1-脫髮症治療市場的市場規模和預測是多少？

2-在脫髮症治療市場的預測期內，有哪些產品、細分市場、應用和領域需要考慮投資？

3-脫髮症治療市場的技術趨勢和法律規範是什麼？

4-脫髮症治療市場主要供應商的市場佔有率是多少？

5-進入脫髮症治療市場合適的型態和策略手段是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 雄性脫髮症和脫髮症的發生率增加
      • 人們對除毛和移植的認知不斷增強
      • 收入水準上升和醫療保健支出增加
    • 抑制因素
      • 脫髮症治療缺乏報銷制度
    • 機會
      • 介紹脫髮症的新治療方法和藥物
      • 加大投資、擴大植髮診所
    • 任務
      • 有關某些脫髮症藥物的有效性和副作用的問題
  • 市場區隔分析
  • 市場趨勢分析
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法律規範

第6章脫髮症治療市場：依疾病類型

  • 脫髮症
  • 全脫髮症
  • 脫髮症
  • 雄性脫髮症
  • 疤痕性脫髮症
  • 牽引脫髮症

第7章脫髮症治療市場：依給藥途徑

  • 注射
  • 口服
  • 外用

第8章脫髮症治療市場：依性別

  • 女士
  • 男性

第9章脫髮症治療市場：依治療方案

  • 蒽甙
  • 皮質類固醇
  • JAK抑制劑
  • Methotrexate
  • 局部免疫治療

第 10 章脫髮症治療市場：按最終用戶分類

  • 皮膚科診所
  • 居家護理

第11章 北美和南美脫髮症治療市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第12章亞太脫髮症治療市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第13章歐洲、中東和非洲的脫髮症治療市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第14章競爭形勢

  • FPNV定位矩陣
  • 市場佔有率分析：依主要企業分類
  • 主要企業競爭情境分析

第15章競爭產品組合

  • 主要公司簡介
    • Aclaris Therapeutics, Inc.
    • AnaptysBio Inc.
    • BiologicsMD, Inc.
    • Cipla, Inc.
    • Cirrus Hair Centers
    • Curallux, LLC
    • Daiichi Sankyo Inc.
    • DR. KURT WOLFF GMBH & CO. KG
    • Dr. Reddy's Laboratories Ltd
    • Eli Lilly and Company
    • Fagron NV by Omega Pharma
    • Follica, Inc.
    • HCell Inc.
    • iGrow Laser
    • iRestore Hair Growth System
    • Johnson & Johnson Services, Inc
    • KNOW Bio LLC
    • Pfizer Inc.
    • RepliCel Life Sciences Inc.
    • Sun Pharmaceutical Industries Ltd.
    • Teva Pharmaceutical Industries Ltd
    • Theradome GB
    • Transitions Hair Pty Ltd.
    • Viviscal
    • Zocdoc, Inc.
  • 主要產品系列

第16章附錄

  • 討論指南
  • 關於許可證和定價
Product Code: MRR-A339DAEFA492

[196 Pages Report] The Alopecia Treatment Market size was estimated at USD 3.26 billion in 2023 and expected to reach USD 3.53 billion in 2024, at a CAGR 8.27% to reach USD 5.69 billion by 2030.

Global Alopecia Treatment Market

KEY MARKET STATISTICS
Base Year [2023] USD 3.26 billion
Estimated Year [2024] USD 3.53 billion
Forecast Year [2030] USD 5.69 billion
CAGR (%) 8.27%
Alopecia Treatment Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Alopecia Treatment Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Alopecia Treatment Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Alopecia Treatment Market, highlighting leading vendors and their innovative profiles. These include Aclaris Therapeutics, Inc., AnaptysBio Inc., BiologicsMD, Inc., Cipla, Inc., Cirrus Hair Centers, Curallux, LLC, Daiichi Sankyo Inc., DR. KURT WOLFF GMBH & CO. KG, Dr. Reddy's Laboratories Ltd, Eli Lilly and Company, Fagron NV by Omega Pharma, Follica, Inc., HCell Inc., iGrow Laser, iRestore Hair Growth System, Johnson & Johnson Services, Inc, KNOW Bio LLC, Pfizer Inc., RepliCel Life Sciences Inc., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd, Theradome GB, Transitions Hair Pty Ltd., Viviscal, and Zocdoc, Inc..

Market Segmentation & Coverage

This research report categorizes the Alopecia Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Disease Type
    • Alopecia Areata
    • Alopecia Totalis
    • Alopecia Universalis
    • Androgenetic Alopecia
    • Cicatricial Alopecia
    • Traction Alopecia
  • Route of Administration
    • Injectable
    • Oral
    • Topical
  • Gender
    • Female
    • Male
  • Treatment Option
    • Anthralin
    • Corticosteroid
    • JAK Inhibitors
    • Methotrexate
    • Topical Immunotherapy
  • End User
    • Dermatology Clinics
    • Homecare Setting
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Alopecia Treatment Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Alopecia Treatment Market?

3. What are the technology trends and regulatory frameworks in the Alopecia Treatment Market?

4. What is the market share of the leading vendors in the Alopecia Treatment Market?

5. Which modes and strategic moves are suitable for entering the Alopecia Treatment Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Alopecia Treatment Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing incidence of androgenetic alopecia and alopecia areata diseases
      • 5.1.1.2. Growing awareness about hair loss and transplantation
      • 5.1.1.3. Rise in income levels and increased healthcare spending
    • 5.1.2. Restraints
      • 5.1.2.1. Lack of reimbursement policies for alopecia treatments
    • 5.1.3. Opportunities
      • 5.1.3.1. Emergence of new alopecia areata treatments and therapeutics
      • 5.1.3.2. Rising investments and expansion of hair transplant clinics
    • 5.1.4. Challenges
      • 5.1.4.1. Issues associated with efficacy and side-effects related to some hair loss treatment therapies
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Alopecia Treatment Market, by Disease Type

  • 6.1. Introduction
  • 6.2. Alopecia Areata
  • 6.3. Alopecia Totalis
  • 6.4. Alopecia Universalis
  • 6.5. Androgenetic Alopecia
  • 6.6. Cicatricial Alopecia
  • 6.7. Traction Alopecia

7. Alopecia Treatment Market, by Route of Administration

  • 7.1. Introduction
  • 7.2. Injectable
  • 7.3. Oral
  • 7.4. Topical

8. Alopecia Treatment Market, by Gender

  • 8.1. Introduction
  • 8.2. Female
  • 8.3. Male

9. Alopecia Treatment Market, by Treatment Option

  • 9.1. Introduction
  • 9.2. Anthralin
  • 9.3. Corticosteroid
  • 9.4. JAK Inhibitors
  • 9.5. Methotrexate
  • 9.6. Topical Immunotherapy

10. Alopecia Treatment Market, by End User

  • 10.1. Introduction
  • 10.2. Dermatology Clinics
  • 10.3. Homecare Setting

11. Americas Alopecia Treatment Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Alopecia Treatment Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Alopecia Treatment Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. FPNV Positioning Matrix
  • 14.2. Market Share Analysis, By Key Player
  • 14.3. Competitive Scenario Analysis, By Key Player

15. Competitive Portfolio

  • 15.1. Key Company Profiles
    • 15.1.1. Aclaris Therapeutics, Inc.
    • 15.1.2. AnaptysBio Inc.
    • 15.1.3. BiologicsMD, Inc.
    • 15.1.4. Cipla, Inc.
    • 15.1.5. Cirrus Hair Centers
    • 15.1.6. Curallux, LLC
    • 15.1.7. Daiichi Sankyo Inc.
    • 15.1.8. DR. KURT WOLFF GMBH & CO. KG
    • 15.1.9. Dr. Reddy's Laboratories Ltd
    • 15.1.10. Eli Lilly and Company
    • 15.1.11. Fagron NV by Omega Pharma
    • 15.1.12. Follica, Inc.
    • 15.1.13. HCell Inc.
    • 15.1.14. iGrow Laser
    • 15.1.15. iRestore Hair Growth System
    • 15.1.16. Johnson & Johnson Services, Inc
    • 15.1.17. KNOW Bio LLC
    • 15.1.18. Pfizer Inc.
    • 15.1.19. RepliCel Life Sciences Inc.
    • 15.1.20. Sun Pharmaceutical Industries Ltd.
    • 15.1.21. Teva Pharmaceutical Industries Ltd
    • 15.1.22. Theradome GB
    • 15.1.23. Transitions Hair Pty Ltd.
    • 15.1.24. Viviscal
    • 15.1.25. Zocdoc, Inc.
  • 15.2. Key Product Portfolio

16. Appendix

  • 16.1. Discussion Guide
  • 16.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. ALOPECIA TREATMENT MARKET RESEARCH PROCESS
  • FIGURE 2. ALOPECIA TREATMENT MARKET SIZE, 2023 VS 2030
  • FIGURE 3. ALOPECIA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. ALOPECIA TREATMENT MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. ALOPECIA TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. ALOPECIA TREATMENT MARKET DYNAMICS
  • FIGURE 7. ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2023 VS 2030 (%)
  • FIGURE 8. ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 10. ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2023 VS 2030 (%)
  • FIGURE 12. ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2023 VS 2030 (%)
  • FIGURE 14. ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 16. ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. AMERICAS ALOPECIA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. AMERICAS ALOPECIA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. UNITED STATES ALOPECIA TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 20. UNITED STATES ALOPECIA TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. ASIA-PACIFIC ALOPECIA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. ASIA-PACIFIC ALOPECIA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA ALOPECIA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA ALOPECIA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 25. ALOPECIA TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 26. ALOPECIA TREATMENT MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. ALOPECIA TREATMENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. ALOPECIA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 6. ALOPECIA TREATMENT MARKET SIZE, BY ALOPECIA AREATA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. ALOPECIA TREATMENT MARKET SIZE, BY ALOPECIA TOTALIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. ALOPECIA TREATMENT MARKET SIZE, BY ALOPECIA UNIVERSALIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. ALOPECIA TREATMENT MARKET SIZE, BY ANDROGENETIC ALOPECIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. ALOPECIA TREATMENT MARKET SIZE, BY CICATRICIAL ALOPECIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. ALOPECIA TREATMENT MARKET SIZE, BY TRACTION ALOPECIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 13. ALOPECIA TREATMENT MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. ALOPECIA TREATMENT MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. ALOPECIA TREATMENT MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 17. ALOPECIA TREATMENT MARKET SIZE, BY FEMALE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. ALOPECIA TREATMENT MARKET SIZE, BY MALE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
  • TABLE 20. ALOPECIA TREATMENT MARKET SIZE, BY ANTHRALIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. ALOPECIA TREATMENT MARKET SIZE, BY CORTICOSTEROID, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. ALOPECIA TREATMENT MARKET SIZE, BY JAK INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. ALOPECIA TREATMENT MARKET SIZE, BY METHOTREXATE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. ALOPECIA TREATMENT MARKET SIZE, BY TOPICAL IMMUNOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 26. ALOPECIA TREATMENT MARKET SIZE, BY DERMATOLOGY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. ALOPECIA TREATMENT MARKET SIZE, BY HOMECARE SETTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS ALOPECIA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES ALOPECIA TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC ALOPECIA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
  • TABLE 70. AUSTRALIA ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 74. CHINA ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
  • TABLE 75. CHINA ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 79. INDIA ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
  • TABLE 80. INDIA ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 84. INDONESIA ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
  • TABLE 85. INDONESIA ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 88. JAPAN ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 89. JAPAN ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
  • TABLE 90. JAPAN ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 93. MALAYSIA ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 94. MALAYSIA ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
  • TABLE 95. MALAYSIA ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 96. PHILIPPINES ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 98. PHILIPPINES ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 99. PHILIPPINES ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
  • TABLE 100. PHILIPPINES ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 101. SINGAPORE ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 103. SINGAPORE ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 104. SINGAPORE ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
  • TABLE 105. SINGAPORE ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 106. SOUTH KOREA ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 108. SOUTH KOREA ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 109. SOUTH KOREA ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
  • TABLE 110. SOUTH KOREA ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 111. TAIWAN ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 113. TAIWAN ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 114. TAIWAN ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
  • TABLE 115. TAIWAN ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 116. THAILAND ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 118. THAILAND ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 119. THAILAND ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
  • TABLE 120. THAILAND ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 121. VIETNAM ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 123. VIETNAM ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 124. VIETNAM ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
  • TABLE 125. VIETNAM ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA ALOPECIA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 132. DENMARK ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 134. DENMARK ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 135. DENMARK ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
  • TABLE 136. DENMARK ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 137. EGYPT ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 139. EGYPT ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 140. EGYPT ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
  • TABLE 141. EGYPT ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 142. FINLAND ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 144. FINLAND ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 145. FINLAND ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
  • TABLE 146. FINLAND ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 147. FRANCE ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 149. FRANCE ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 150. FRANCE ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
  • TABLE 151. FRANCE ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 152. GERMANY ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 154. GERMANY ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 155. GERMANY ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
  • TABLE 156. GERMANY ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 157. ISRAEL ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 159. ISRAEL ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 160. ISRAEL ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
  • TABLE 161. ISRAEL ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 162. ITALY ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 164. ITALY ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 165. ITALY ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
  • TABLE 166. ITALY ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 167. NETHERLANDS ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 169. NETHERLANDS ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 170. NETHERLANDS ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
  • TABLE 171. NETHERLANDS ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 172. NIGERIA ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 174. NIGERIA ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 175. NIGERIA ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
  • TABLE 176. NIGERIA ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 177. NORWAY ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 179. NORWAY ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 180. NORWAY ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
  • TABLE 181. NORWAY ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 182. POLAND ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 184. POLAND ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 185. POLAND ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
  • TABLE 186. POLAND ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 187. QATAR ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 189. QATAR ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 190. QATAR ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
  • TABLE 191. QATAR ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 192. RUSSIA ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 194. RUSSIA ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 195. RUSSIA ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
  • TABLE 196. RUSSIA ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 200. SAUDI ARABIA ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
  • TABLE 201. SAUDI ARABIA ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH AFRICA ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH AFRICA ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH AFRICA ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
  • TABLE 206. SOUTH AFRICA ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 207. SPAIN ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 209. SPAIN ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 210. SPAIN ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
  • TABLE 211. SPAIN ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 212. SWEDEN ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 214. SWEDEN ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 215. SWEDEN ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
  • TABLE 216. SWEDEN ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 217. SWITZERLAND ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 219. SWITZERLAND ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 220. SWITZERLAND ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
  • TABLE 221. SWITZERLAND ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 222. TURKEY ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 224. TURKEY ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 225. TURKEY ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
  • TABLE 226. TURKEY ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED ARAB EMIRATES ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED ARAB EMIRATES ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED KINGDOM ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED KINGDOM ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED KINGDOM ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
  • TABLE 236. UNITED KINGDOM ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 237. ALOPECIA TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 238. ALOPECIA TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 239. ALOPECIA TREATMENT MARKET LICENSE & PRICING